Crescent Biopharma · 2 months ago
Vice President, Drug Discovery
Crescent Biopharma is a company focused on advancing oncology therapies for cancer patients. They are seeking a Vice President of Drug Discovery to oversee drug discovery efforts, lead research teams, and manage departmental budgets while driving innovation in antibody and ADC programs.
BiotechnologyHealth CareMedical Device
Responsibilities
Guide the strategic approach for target selection, antibody discovery and therapeutic approach to identify and develop novel drug candidates
Build, lead and develop high performing research & preclinical teams
Lead technological innovations to drive continual improvements and optimization of Crescent's antibody and ADC programs enabling continued success as the organization grows
Effectively manage a departmental budget and deliver results based on work conducted at CROs and external partners
Represent the company at scientific conferences and author high impact peer reviewed publications
Responsible for delivery of research and development reports to support regulatory submissions (IND/IMPD, information requests, amendments, briefing books, BLA/MAA etc.)
Qualification
Required
Ph.D. in Life Sciences with a minimum of 15 years of combined R&D experience in the biotech/biopharmaceutical industry and world-class academic institutions
M.S. with equivalent experience will also be considered
Demonstrated career growth and experience gained in leading growing R&D organizations
Deep experience in drug discovery and development in oncology
Successful leadership of antibody and ADC program(s) from discovery to preclinical development and commercialization
Recognized leader and expert with a track record in cancer research, immunology and cell biology fields
Inspires teams by being intellectually and scientifically curious, is extremely scientifically rigorous and creative and creates an environment where imaginative and constructive dialog can flourish, conflict is well-managed and complex issues are driven to full resolution
Demonstrated success in attracting world-class scientific talent
Hands on experience with regulatory requirements for the development and approval of novel therapeutics in oncology
Benefits
100% employer-paid benefits package.
Flexible PTO.
Two, one-week company-wide shutdowns each year.
Access to resources, mentorship, and growth opportunities.
Medical, dental, vision, life insurance, short- and long-term disability.
Company’s savings plan (401(k)).
Long-term incentive program.
Unlimited PTO; Sick time – 10 days per calendar year; Holiday pay, including two Company shut downs; Parental Leave – 16 weeks within one year of the birth/adoption/foster care of a child; FMLA; Military Leave.
Company
Crescent Biopharma
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Funding
Current Stage
Public CompanyTotal Funding
$585MKey Investors
Fairmount Funds Management
2025-12-04Post Ipo Equity· $185M
2025-06-16Post Ipo Equity· $200M
2025-06-16IPO
Recent News
2026-01-06
Company data provided by crunchbase